| Dec'19 | Dec'18 | Dec'17 | Dec'16 | |||
|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||
Net loss | ||||||
-105,146 | -75,657 | -20,000 | -1,941 | |||
Adjustment to reconcile net loss to net cash from operating activities: | ||||||
Depreciation and amortization | ||||||
296 | 417 | 207 | 213 | |||
Amortization/Accretion on marketable securities | ||||||
572 | - | - | - | |||
Stock-based compensation | ||||||
29,967 | 30,642 | 6,300 | 1,967 | |||
Fair value adjustment of warrants for preferred shares | ||||||
- | - | 168 | 2,740 | |||
Realized loss on sale of short-term investment | ||||||
- | -100 | - | - | |||
Amortization of right of use asset | ||||||
1,028 | - | - | - | |||
Lease liability | ||||||
910 | - | - | - | |||
Changes in operating assets and liabilities: | ||||||
Decrease (increase) in inventory | ||||||
- | -316 | 211 | 105 | |||
Decrease in accounts receivable | ||||||
- | - | -83 | 83 | |||
Increase in prepaid expenses and other current assets | ||||||
394 | -318 | 562 | -739 | |||
Decrease in accounts payable and accrued expenses | ||||||
2,928 | 4,205 | 2,534 | 481 | |||
(Decrease) increase in deferred revenues | ||||||
- | -650 | 650 | - | |||
Decrease in employee related accrued expenses | ||||||
1,786 | 2,975 | 1,263 | 178 | |||
Net cash used in operating activities | ||||||
-71,017 | -37,334 | -9,568 | 4,189 | |||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||
Sale of short-term investments | ||||||
- | -35,901 | - | - | |||
Purchase of marketable securities | ||||||
197,686 | - | 36,001 | - | |||
Maturities of marketable securities | ||||||
52,590 | - | - | - | |||
Change in restricted deposit | ||||||
172 | 54 | 5 | 24 | |||
Purchases of property and equipment | ||||||
325 | 560 | 271 | 695 | |||
Net cash provided by (used in) investing activities | ||||||
-145,593 | 35,287 | -36,277 | -719 | |||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||
Proceeds from exercise of options into ordinary shares | ||||||
3,664 | 2,401 | 404 | - | |||
Issuance of ordinary shares, net of issuance expenses | ||||||
161,662 | 64,235 | 60,841 | - | |||
Proceeds from exercise of warrants for preferred shares | ||||||
- | - | 382 | 570 | |||
Issuance cost for shelf filing | ||||||
76 | - | - | 579 | |||
Issuance cost for secondary offering | ||||||
- | 215 | 42 | - | |||
Net cash provided by financing activities | ||||||
165,250 | 66,421 | 61,585 | -9 | |||
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | ||||||
-51,360 | 64,374 | 15,740 | 3,461 | |||
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||||||
Non-cash new lease liabilities | ||||||
1,741 | - | - | - | |||
Non-cash issuance cost | ||||||
188 | 102 | 202 | 181 | |||
Exercise of warrants to preferred shares | ||||||
- | - | 4,732 | - | |||